Asiamedic Health Screening

Announcements

< Previous Page  |  Next Page >

Date Title
Apr 09, 2020 Extension Of Time To Hold Annual General Meeting For The Financial Year Ended 31 December 2019
Apr 07, 2020 Business Update - COVID-19 Circuit Breaker Measures
Feb 24, 2020 Financial Statements And Related Announcement - Full Yearly Results
Jan 14, 2020 Disclosure Of Interest/ Changes In Interest Of Director/ Chief Executive Officer - Changes Of Interest Of Director
Jan 14, 2020 Disclosure Of Interest/ Changes In Interest Of Substantial Shareholder(s)/ Unitholder(s) - Changes In Interest Of Substantial Shareholder
Jan 13, 2020 Proposed Renounceable Non-Underwritten Rights Issue Of Up To 1,561,952,500 New Ordinary Shares In The Capital Of The Company - Listing And Quotation For The Rights Shares
Jan 10, 2020 Change - Announcement Of Appointment Of Chief Operating Officer
Jan 10, 2020 Proposed Renounceable Non-Underwritten Rights Issue Of Up To 1,561,952,500 New Ordinary Shares In The Capital Of The Company - Results Of Rights Issue
Jan 07, 2020 Response To SGX-ST Queries On The Re-Designation Of The Lead Independent Director
Dec 31, 2019 Reconstitution Of Board Committees And Re-Designation Of Lead independent Director To Independent Director
Dec 17, 2019 Proposed Renounceable Non-Underwritten Rights Issue Of Up To 1,561,952,500 New Ordinary Shares In The Capital Of The Company - Lodgement And Despatch Of The Offer Information Statement And Expected Timetable Of Key Events
Dec 17, 2019 Proposed Renounceable Non-Underwritten Rights Issue Of Up To 1,561,952,500 New Ordinary Shares In The Capital Of The Company - Receipt Of Listing And Quotation Notice
Dec 06, 2019 Proposed Renounceable Non-Underwritten Rights Issue Of Up To 1,561,952,500 New Ordinary Shares In The Capital Of The Company - Notice Of Books Closure Date
Dec 06, 2019 Proposed Renounceable Non-Underwritten Rights Issue Of Up To 1,561,952,500 New Ordinary Shares In The Capital Of The Company - Receipt Of Listing And Quotation Notice
Dec 05, 2019 Proposed Renounceable Non-Underwritten Rights Issue Of Up To 1,561,952,500 New Ordinary Shares In The Capital Of The Company - Receipt Of Listing And Quotation Notice
Nov 29, 2019 Results Of Extraordinary General Meeting
Nov 13, 2019 Proposed Renounceable Non-Underwritten Rights Issue Of Up To 1,561,952,500 New Ordinary Shares In The Capital Of The Company - Circular To Shareholders
Nov 13, 2019 Notice Of Extraordinary General Meeting
Oct 11, 2019 Proposed Renounceable Non-Underwritten Rights Issue Of Up To 1,561,952,500 New Ordinary Shares In The Capital Of The Company - Update On Receipt Of Whitewash Waiver From The Securities Industry Council And Appointment Of Independent Financial Adviser
Oct 01, 2019 Change - Announcement Of Appointment Of Independent Director

< Previous Page  |  Next Page >